Načítá se...
CX-4945: the protein kinase CK2 inhibitor and anti-cancer drug shows anti-fungal activity
CX-4945 is a selective inhibitor of protein kinase CK2 exhibiting clinical significance. Its antitumor properties arise from the abrogation of CK2-mediated pro-survival cellular pathways. The presented data reveal the influence of CX-4945 on the growth of yeast cells showing variable potency against...
Uloženo v:
| Vydáno v: | Mol Cell Biochem |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632345/ https://ncbi.nlm.nih.gov/pubmed/28501934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11010-017-3068-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|